Skip to content

Healthcare club Trecento1023


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

  • Medium
  • enEnglish
    • frFrench
Trecento AMTrecento AM
Trecento AM
Un site utilisant WordPress
  • Home
  • Trecento
    • Our History
    • Our Philosophy
    • Our Team
    • Our PRI Commitment
  • Products
    • Trecento Santé “healthcare”
      • Presentation of Trecento Santé
      • Page of the fund
    • Trecento Robotique
      • Presentation of Trecento Robotique
      • Page of the fund
    • Employee Savings Plan
    • Wealth Management
  • How to subscribe
  • News
    • News
    • Medium
    • Interviews BFM Business
    • Trecento sagas
    • Quarterly reports
  • Contact
    • Contact
    • Join us
  • Home
  • Trecento
    • Our History
    • Our Philosophy
    • Our Team
    • Our PRI Commitment
  • Products
    • Trecento Santé “healthcare”
      • Presentation of Trecento Santé
      • Page of the fund
    • Trecento Robotique
      • Presentation of Trecento Robotique
      • Page of the fund
    • Employee Savings Plan
    • Wealth Management
  • How to subscribe
  • News
    • News
    • Medium
    • Interviews BFM Business
    • Trecento sagas
    • Quarterly reports
  • Contact
    • Contact
    • Join us

Pharmaceutiques – M&A, the race for opportunities

Christophe Pouchoy, Managing Director and Managing Director of Trecento Asset Management, co-manager of the Trecento Santé fund, answered questions from the Pharmaceutiques magazine about the recent acquisitions and some reconciliations of big pharma and major biotech companies.

“Because, before buying a company, the laboratories study the expected sales multiples over the coming years and the peak sales anticipated in the next three to five years. So, they’re focusing on the 2022-2023 horizon, the necessary deadline for the companies they want to buy back, to register their (…)”Résultat de recherche d'images pour "Pharmaceutiques logo"Read the article by clicking here (available in French only)

Partager cet article

Articles similaires

Challenges – Marriage of convenience between Sanofi and Abbott on diabetes
17 September 2019
Idéal Investisseur Magazine – Alice Lhabouz: entrepreneurship as a vocation
13 August 2019
Challenges – Will homeopathy always be reimbursed by complementary health?
18 July 2019
Challenges – Homéopathie: Boiron facing the non-refund policy
28 June 2019
Our videos
Trecento AM on twitter
#Kadcyla (HER2-positive early #breast #cancer) from #Genentech (#Roche unit) met primary endpoint in a Ph III study… https://t.co/YpSjAHlTOU
Club Trecento Santé @Trecento_Sante October 15, 2018
@genentech (filiale de @Roche) a annoncé des résultats positifs en Ph III pour le #Kadcyla (#cancer du #sein HER-2… https://t.co/hv58Kws4Z4
1
Club Trecento Santé @Trecento_Sante October 15, 2018
#Capio recommended shareholders to accept #RamsayGDS new takeover price at 58SEK per share (+20% from the previous… https://t.co/scqePlFGlW
Club Trecento Santé @Trecento_Sante October 10, 2018
#Capio semble se satisfaire de la révision à la hausse de l'offre d'achat par @RamsayGDS (58 SEK par action) et rec… https://t.co/zDTZZUTfp8
1
Club Trecento Santé @Trecento_Sante October 10, 2018
#RamsayGDS increases #CAPIO offer price by almost 20% at 58 SEK per share, versus 48.5 #M&A #Healthcare #Services… https://t.co/uisxxeAnaM
Club Trecento Santé @Trecento_Sante October 8, 2018
@RamsayGDS relève son offre sur #CAPIO de près de 20% à 58 SEK par action, contre 48,5 précédemment… https://t.co/ym0Hb6UEXL
1
Club Trecento Santé @Trecento_Sante October 8, 2018
#Roche won #US_FDA regulatory approval to sell #Hemlibra (#emicizumab) to the largest portion of #hemophilia patien… https://t.co/2g1ceoWFcv
Club Trecento Santé @Trecento_Sante October 5, 2018
@Roche obtient le feu vert de la @US_FDA pour la commercialisation d'#Hemlibra (#emicizumab) auprès du plus large g… https://t.co/d6RugV9FBu
1 1
Club Trecento Santé @Trecento_Sante October 5, 2018
Positive results in a Ph III study for the #Baloxavir #marboxil from #Roche, which aims to treat #Flu patients at r… https://t.co/VNPZRFBWQp
Club Trecento Santé @Trecento_Sante October 4, 2018
Données positives en Ph III pour le #Baloxavir #marboxil de @Roche destiné à traiter les patients atteints de la… https://t.co/IdRp9AMaMJ
1 2
Club Trecento Santé @Trecento_Sante October 4, 2018
#Sanofi completes sale of its #Generics division to #Advent International for about 1.9 billion of euros. The Compa… https://t.co/F5tc2EZJDu
Club Trecento Santé @Trecento_Sante October 1, 2018
@sanofi finalise la cession de sa division #Génériques à #Advent International (Private Equity) pour 1,9 milliard d… https://t.co/lG4Mw8PEUM
1
Club Trecento Santé @Trecento_Sante October 1, 2018
@AlexionPharma to buy #Symtimmune, biotech company which currently has a treatment for autoimmune hemolytic anemia… https://t.co/1gmWqea2i7
1
Club Trecento Santé @Trecento_Sante September 26, 2018
@AlexionPharma rachète #Symtimmune, biotech développant notamment un traitement pour l'#anémie hémolytique auto-imm… https://t.co/yY0yZxaVvD
1
Club Trecento Santé @Trecento_Sante September 26, 2018
At #TCT2018, manufacturers of #cardiologic medical equipment have demonstrated improvements in their equipment and… https://t.co/gsxWH3pn05
Club Trecento Santé @Trecento_Sante September 25, 2018
Au #TCT2018, les fabricants d'équipements médicaux en #cardiologie ont fait la démonstration d'améliorations de leu… https://t.co/fJ2s8EyeZP
4 4
Club Trecento Santé @Trecento_Sante September 25, 2018
Diabetics are at increased risk of heart problems, making the #cardiovascular (CV) profile of medicines to treat th… https://t.co/sfW3ABUzbc
1
Club Trecento Santé @Trecento_Sante September 24, 2018
La prise en compte des événements #cardiovasculaires dans les traitements contre le #diabète devient de plus en plu… https://t.co/gF9mDxk3Na
1 2
Club Trecento Santé @Trecento_Sante September 24, 2018
RT @Trecento_Robot: @Medtronic rachète @MazorRobotics, spécialiste des #robots #chirurgicaux dans le domaine interventionnel de la #colonne…
2
Club Trecento Santé @Trecento_Sante September 21, 2018
According to sources familiar with the matter, #Nestlé, #Unilever and #Coca-Cola could buy #Horlicks, a nutrition b… https://t.co/JzJOJJ5oQ5
1
Club Trecento Santé @Trecento_Sante September 19, 2018
Dernière actualité
  • Challenges – Marriage of convenience between Sanofi and Abbott on diabetes
    17 September 2019
33 rue de Miromesnil
75008 Paris
Tel • +33 (0)1 57 13 55 55
Fax • +33 (0)1 42 65 01 70
Mail • contact@trecento-am.com

Find us on:

FacebookTwitterYouTubeLinkedinWebsite
  • Legal notices
  • Regulatory information
  • Contact